eATP increases tumor cell survival and drug resistance by increased glucose transporter 1 (GLUT1) expression through the P2X7R-PI3K-Akt and hypoxia-inducible factor 1α (HIF-1α) (17). This evidence concerns the gene SLC2A1 and neoplasm.